TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Lemongrass Medical Consulting&Invest AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,341
|
1,318
|
1,379 |
Financial expenses |
6
|
9
|
42 |
Earnings before taxes |
-99
|
211
|
-18 |
EBITDA |
-95
|
220
|
21 |
Total assets |
255
|
332
|
0 |
Current assets |
169
|
252
|
0 |
Current liabilities |
437
|
409
|
0 |
Equity capital |
-181
|
-77
|
0 |
- share capital |
101
|
95
|
0 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-71.0%
|
-23.2% | |
Turnover per employee |
1,341
|
1,318
|
1,379 |
Profit as a percentage of turnover |
-7.4%
|
16.0%
|
-1.3% |
Return on assets (ROA) |
-36.5%
|
66.3% | |
Current ratio |
38.7%
|
61.6% | |
Return on equity (ROE) |
54.7%
|
-274.0% | |
Change turnover |
-70
|
-20
|
104 |
Change turnover % |
-5%
|
-1%
|
8% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.